High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
Guardado en:
Autores principales: | Rosmely Hernandez, Kathryn M LaPorte, Sunnie Hsiung, Alicia Santos Savio, Thomas R Malek |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49472d5967644776960427a0c7300573 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
por: Nicholas F. Kuhn, et al.
Publicado: (2020) -
Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.
por: Xinjuan Liu, et al.
Publicado: (2013) -
Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity
por: Deyong Song, et al.
Publicado: (2021) -
Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor
por: Bruce M. Hall, et al.
Publicado: (2021) -
CD4+CD25+ Regulatory T cell ontogeny and preferential migration to the cecal tonsils in chickens.
por: Revathi Shanmugasundaram, et al.
Publicado: (2012)